Skip to main content

Trends in Antimalarial Drug Use in Africa

Author(s): Flegg, Jennifer A.; Gharbi, Myriam; Hopkins Sibley, Carol; Shewchuk, Tanya; Metcalf, C. Jessica E.; et al

Download
To refer to this page use: http://arks.princeton.edu/ark:/88435/pr14z0q
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFlegg, Jennifer A.-
dc.contributor.authorGharbi, Myriam-
dc.contributor.authorHopkins Sibley, Carol-
dc.contributor.authorShewchuk, Tanya-
dc.contributor.authorMetcalf, C. Jessica E.-
dc.contributor.authorGuerin, Philippe J.-
dc.contributor.authorVenkatesan, Meera-
dc.date.accessioned2020-01-21T22:41:31Z-
dc.date.available2020-01-21T22:41:31Z-
dc.date.issued2013-11-06en_US
dc.identifier.citationFlegg, Jennifer A., Gharbi, Myriam, Hopkins Sibley, Carol, Shewchuk, Tanya, Metcalf, C. Jessica E., Guerin, Philippe J., Venkatesan, Meera. (2013). Trends in Antimalarial Drug Use in Africa. The American Journal of Tropical Medicine and Hygiene, 89 (5), 857 - 865. doi:10.4269/ajtmh.13-0129en_US
dc.identifier.issn0002-9637-
dc.identifier.urihttp://arks.princeton.edu/ark:/88435/pr14z0q-
dc.description.abstractResistance to chloroquine (CQ) and sulphadoxine-pyrimethamine (SP) led the World Health Organization (WHO) to recommend changes in national drug policies. The time between policy changes and their implementation profoundly affects program impact. We developed a model based on data on antimalarial treatments, extracted from household surveys and national antimalarial policy information from the literature. Drug use in each country during the time period 1999–2011 and the trend in reduction of CQ use after policy change were estimated. The SP use estimates were correlated with the prevalence of a molecular marker associated with SP resistance. There was no spatial pattern in the country-level rate of reduction of CQ use, after policy change. In East Africa SP drug use was strongly correlated to resistance. If artemisinin resistance spreads to, or emerges in, Africa this methodology will be a valuable tool to estimate actual drug use and its impact on changes in drug efficacy.en_US
dc.format.extent857 - 865en_US
dc.language.isoen_USen_US
dc.relation.ispartofThe American Journal of Tropical Medicine and Hygieneen_US
dc.rightsFinal published version. Article is made available in OAR by the publisher's permission or policy.en_US
dc.titleTrends in Antimalarial Drug Use in Africaen_US
dc.typeJournal Articleen_US
dc.identifier.doidoi:10.4269/ajtmh.13-0129-
dc.identifier.eissn1476-1645-
pu.type.symplectichttp://www.symplectic.co.uk/publications/atom-terms/1.0/journal-articleen_US

Files in This Item:
File Description SizeFormat 
Trends_antimalarial_drug_use_Africa_2013.pdf1.25 MBAdobe PDFView/Download
Supp_Trends_antimalarial_drug_use_Africa_2013.pdf1.34 MBAdobe PDFView/Download


Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.